About Us

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest global organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure through our four pillars: Research, Education, Support, and Advocacy.

About the IMF - Improving Lives, Finding the Cure Through Research and Patient Care
What We Do

The International Myeloma Foundation is dedicated to finding a cure for those living with multiple myeloma. We have a range of initiatives to make this happen.


Because "Knowledge Is Power," the IMF brings educational seminars and workshops to communities near you, and provides a library of publications on multiple myeloma care.


Since our inception in 1990, the IMF has supported and met in-person with thousands of patients globally. At our annual Support Group Leaders Summit, the reach is to more than 6,000 patients and caregivers. 


The IMF’s Advocacy team has educated and empowered thousands of individuals who make a positive impact each year on issues critical to the myeloma community in the U.S. and worldwide.

Our People

The people of the IMF — our Board of Directors, our management, and our staff — are here to help you. We invite you to learn more about our team.

2024 IMF Staff Retreat group photo
Image Left
globe as a puzzle and stethoscope
Our Partners

We partner with organizations all over the world. Together, we promote awareness of multiple myeloma and encourage measures to prevent and combat the disease.

Image Left
2023 Innovation and Impact Report promote
Our Impact

Because of your support, the International Myeloma Foundation (IMF) made huge strides in myeloma research, education, support, and advocacy in 2023. Read the full 2023 Innovation and Impact Report now. 

Image Right
2023-2027 IMF's Global Strategy Plan
Our Strategy

IMF President and CEO Yelak Biru, who is also a myeloma survivor, unveils the organization’s Global Strategy Plan for 2023-2027. According to Yelak, these are “a set of strategies” that were “written over the last nine months with input from patients we serve, global key opinion leaders, industry partners, and other collaborators. The strategy focuses on purposeful targeted innovation in the service of those who need us most.”

Image Left
Display paragraphs below sidebar menu

Source URL: https://www.myeloma.org/about-imf